MeiraGTx: Bota-Vec Program Advancing With Milestones Being Met [Seeking Alpha]
MeiraGTx Holdings plc - Ordinary Shares (MGTX)
Company Research
Source: Seeking Alpha
Enrollment completed in ongoing phase 3 LUMEOS study, using bota-vec for the treatment of patients with XLRP; Potential results could be released end of 2024 or in early 2025. The global Retinitis Pigmentosa market size is expected to reach $20.47 billion by 2029; It is said that 10% to 15% of RP patients have XLRP. MeiraGTx established asset purchase agreement with Johnson & Johnson whereby it would be entitled to receive upfront cash payment of $130 million and be eligible to earn up to $285 million in milestone payments. Looking for a portfolio of ideas like this one? Members of Biotech Analysis Central get exclusive access to our subscriber-only portfolios. Learn More » MeiraGTx Holdings plc NASDAQ: MGTX ) has been advancing the use of a gene therapy in its pipeline known as botaretigene sparoparvovec [bota-vec] for the treatment of patients with RPGR-associated X-linked Retinitis Pigmentosa [XLRP]. It has been doing so in collaboration with its partner Johnson & Johnson
Show less
Read more
Impact Snapshot
Event Time:
MGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MGTX alerts
High impacting MeiraGTx Holdings plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MGTX
News
- MeiraGTx Holdings plc (NASDAQ:MGTX): Is Breakeven Near? [Yahoo! Finance]Yahoo! Finance
- MeiraGTx to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- MeiraGTx to Participate in Upcoming Investor ConferencesGlobeNewswire
- MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference [Yahoo! Finance]Yahoo! Finance
- MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual ConferenceGlobeNewswire
MGTX
Earnings
- 11/14/23 - Miss
MGTX
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- 4/25/24 - Form DEF
- MGTX's page on the SEC website